• 제목/요약/키워드: Survival protein

검색결과 1,222건 처리시간 0.027초

Application of the Combination of Soybean Lecithin and Whey Protein Concentrate 80 to Improve the Bile Salt and Acid Tolerance of Probiotics

  • Gou, Xuelei;Zhang, Libo;Zhao, Shiwei;Ma, Wanping;Yang, Zibiao
    • Journal of Microbiology and Biotechnology
    • /
    • 제31권6호
    • /
    • pp.840-846
    • /
    • 2021
  • To improve the bile salt and acid tolerance of probiotics against gastrointestinal stresses, we investigated the effects of soybean lecithin and whey protein concentrate (WPC) 80 on the bile salt tolerance of Lacticaseibacillus paracasei L9 using a single-factor methodology, which was optimized using response surface methodology (RSM). The survival rate of L. paracasei L9 treated with 0.3% (w/v) bile salt for 2.5 h, and combined with soybean lecithin or WPC 80, was lower than 1%. After optimization, the survival rate of L. paracasei L9 incubated in 0.3% bile salt for 2.5 h reached 52.5% at a ratio of 0.74% soybean lecithin and 2.54% WPC 80. Moreover, this optimized method improved the survival rate of L. paracasei L9 in low pH condition and can be applied to other lactic acid bacteria (LAB) strains. Conclusively, the combination of soybean lecithin and WPC 80 significantly improved the bile salt and acid tolerance of LAB. Our study provides a novel approach for enhancing the gastrointestinal tolerance of LAB by combining food-derived components that have different properties.

Clinical Outcome of Implants Placed in Grafted Maxillary Sinus Using Recombinant Human Bone Morphogenetic Protein-2: A 5-year Follow-Up Study

  • Yu-Jeong Baek;Jin-Ho Lee;Hyo-Jeong Kim;Bok-Joo Kim;Jang-Ho Son
    • Journal of Korean Dental Science
    • /
    • 제17권1호
    • /
    • pp.45-52
    • /
    • 2024
  • Purpose: To investigate the 5-year outcome of dental implants placed in a grafted maxillary sinus using recombinant human bone morphogenetic protein-2 (rhBMP-2). Materials and Methods: We retrospectively analyzed 27 implants after maxillary sinus floor augmentation (MSFA) using rhBMP-2 in 16 patients between January 2016 and March 2017. The study evaluated two outcome variables: (1) 5-year cumulative survival and success rate of the implant after functional loading and (2) marginal bone loss (MBL) for implant failure. Results: The average residual bone height was 4.78±1.53 mm. The healing period before loading was 8.35±2.34 months. The crown-to-implant ratio was 1.31±0.26. The 5-year cumulative survival and success rate after functional loading were 100% and 96.3%, respectively. The 5-year average MLB was 0.89±0.82 mm. Conclusion: Placing dental implants with MSFA using rhBMP-2 is a reliable procedure with favorable long-term survival and success rates.

Activating Transcription Factor 1 is a Prognostic Marker of Colorectal Cancer

  • Huang, Guo-Liang;Guo, Hong-Qiang;Yang, Feng;Liu, Ou-Fei;Li, Bin-Bin;Liu, Xing-Yan;Lu, Yan;He, Zhi-Wei
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제13권3호
    • /
    • pp.1053-1057
    • /
    • 2012
  • Objective: Identifying cancer-related genes or proteins is critical in preventing and controlling colorectal cancer (CRC). This study was to investigate the clinicopathological and prognostic value of activating transcription factor 1 (ATF1) in CRC. Methods: Protein expression of ATF1 was detected using immunohistochemistry in 66 CRC tissues. Clinicopathological association of ATF1 in CRC was analyzed with chi-square test or Fisher's exact test. The prognostic value of ATF1 in CRC is estimated using the Kaplan-Meier analysis and Cox regression models. Results: The ATF1 protein expression was significantly lower in tumor tissues than corresponding normal tissues (51.5% and 71.1%, respectively, P = 0.038). No correlation was found between ATF1 expression and the investigated clinicopathological parameters, including gender, age, depth of invasion, lymph node status, metastasis, pathological stage, vascular tumoral emboli, peritumoral deposits, chemotherapy and original tumor site (all with P > 0.05). Patients with higher ATF1 expression levels have a significantly higher survival rate than that with lower expression (P = 0.026 for overall survival, P = 0.008 for progress free survival). Multivariate Cox regression model revealed that ATF1 expression and depth of invasion were the predictors of the overall survival (P = 0.008 and P = 0.028) and progress free survival (P = 0.002 and P = 0.005) in CRC. Conclusions: Higher ATF1 expression is a predictor of a favorable outcome for the overall survival and progress free survival in CRC.

생지황(生地黃)이 혈관신생, 세포생존 및 염증관련 단백질발현에 미치는 영향 (The Effects of Rehmannia glutinosa on the Protein Expression Related to the Angiogenesis, Cell Survival and Inflammation)

  • 김성범;김경준
    • 한방안이비인후피부과학회지
    • /
    • 제19권3호통권31호
    • /
    • pp.22-33
    • /
    • 2006
  • Objective : Angiogenesis induced by hypoxia and inflammation are an essential process of solid tumors and psoriasis. We researched the HIF-1 ${\alpha}$ (hypoxia inducible factor 1 alpha), VEGF(Vascular Endothelial Growth Factor), survival related PI3K-Akt, and inflammation related COX-2 protein expressions to get the information of the mechanism and effects of Rehmannia glutinosa in HepG2 and HaCaT cell lines. Method : To investigate the roles of the Rehmannia glutinosa extract, we performed MTS assay and western blots using HaCaT cells and HepG2 cells. HaCaT cells and HepG2 cells were treated with $50{\mu}g/ml$ and $100{\mu}g/ml$ Rehmannia glutinosa extracts. After 4hrs, HaCaT cells were treated with IGF-II protein for 24hrs and HepG2 cells were treated with $CoCl_2$. Results : 1. We could ohserve that the reduction of the protein level of HIT-1 ${\alpha}$ induced by IGF-II in HaCaT cells. 2. We Could ohserve that the decreased PI3K-Akt and COX-2 expression level by Rehmannia glutinosa extracts treated in HaCaT cells independently ith ERK1/2. 3. We could observe that the reduction of the protein level of HIF-1 ${\alpha}$ induced by $CoCl_2$ in HepG2 cells. Conclusion : These results suggest that Rehmannia glutinosa extracts contributes to the anti-survival pathway and anti-inflammatory activities. Also, we could assume that Rehmannia glutinosa act as anti-inflanmmatory or anti-hypoxia agents via reduction of COX-2 and HIF-1 ${\alpha}$.

  • PDF

Identification of p54nrb and the 14-3-3 Protein HS1 as TNF-α-Inducible Genes Related to Cell Cycle Control and Apoptosis in Human Arterial Endothelial Cells

  • Stier, Sebastian;Totzke, Gudrun;Grunewald, Elisabeth;Neuhaus, Thomas;Fronhoffs, Stefan;Schoneborn, Silke;Vetter, Hans;Ko, Yon
    • BMB Reports
    • /
    • 제38권4호
    • /
    • pp.447-456
    • /
    • 2005
  • TNF-$\alpha$ plays a pivotal role in inflammation processes which are mainly regulated by endothelial cells. While TNF-$\alpha$ induces apoptosis of several cell types like tumor cells, endothelial cells are resistant to TNFa mediated cell death. The cytotoxic effects of TNF-$\alpha$ on most cells are only evident if RNA or protein synthesis is inhibited, suggesting that de novo RNA or protein synthesis protect cells from TNF-$\alpha$ cytotoxicity, presumably by NF-${\kappa}B$ mediated induction of protective genes. However, the cytoprotective genes involved in NF-${\kappa}B$ dependent endothelial cell survival have not been sufficiently identified. In the present study, the suppression subtractive hybridization (SSH) method was employed to identify rarely transcribed TNF-$\alpha$ inducible genes in human arterial endothelial cells related to cell survival and cell cycle. The TNF-$\alpha$-induced expression of the RNA binding protein $p54^{nrb}$ and the 14-3-3 protein HS1 as shown here for the first time may contribute to the TNF-$\alpha$ mediated cell protection of endothelial cells. These genes have been shown to play pivotal roles in cell survival and cell cycle control in different experimental settings. The concerted expression of these genes together with other genes related to cell protection and cell cycle like DnaJ, $p21^{cip1}$ and the ubiquitin activating enzyme E1 demonstrates the identification of new genes in the context of TNF-$\alpha$ induced gene expression patterns mediating the prosurvival effect of TNF-$\alpha$ in endothelial cells.

원발성 폐암에서 종양억제유전자 RB와 p53 단백질 발현양상과 예후와의 상관관계 (Expression Pattern of RB and p53 Proteins and its Correlation with Prognosis in Primary Lung Cancer)

  • 이상용;허혜경;최필조;우종수;홍숙희
    • Journal of Chest Surgery
    • /
    • 제29권11호
    • /
    • pp.1223-1231
    • /
    • 1996
  • 72예의 원발성 폐암조직에서 두 종양억제유전자 RB와 p53의 단백질 발현 빈도를 면역조직화학적 방법으로 검출한 결과 RB 단백질 발현은 38예 (52.8%)에서 감소하거나 소실되었고, 변이형 p53 단백질은 35예(48.6%)에서 발현을 보였다. 이들의 발현 빈도는 폐암의 조직형에 따라 유의한 차이를 보여 RB는 선암에서 그리고 p53은 편평세포암에서 발현율이 높았다(p<0.05). 그러나 임상 병기와는 두 단백질의 발현율과는 상관이 없었다. 폐암 환자의 2년 생존율은 두 단백질 발현의 변화가 동반된 군(RB-/p53+)에서 22.4%, 두 단백질 발현의 변화가 전혀 없는 군(RB+/p53-)에서 63.1%로 두 군 사이에 통계적으로 유의한 차이를 보였다(p<0.05).본 연구에서 RB와 p53단백질의 발현의 유무가 원발성 폐암 환자의 생존율과 관련이 있음을 나타내었고, 특히 RB가 원발성 폐암의 예후에 가장 큰 영향을 미치는 인자임을 나타내었다.

  • PDF

대하 (Penaeus chinensis)의 단백질요구량과 단백질원으로서 대두박의 이용 (Optimum Level of Protein and the Possibility of Replacement of Fish Meal by Soybean Meal in Feeds for Fleshy Shrimp, Penaeus chinensis)

  • 김현준;허성범
    • 한국양식학회지
    • /
    • 제6권3호
    • /
    • pp.173-186
    • /
    • 1993
  • 대하의 단백질요구량과 배합 사료에 어분 대신 대두백으로 대체하고 여기에 오징어유를 첨가한 먹이에 대한 성장 결과는 다음과 같다. 배합 사료를 먹이로 공급할 때 단백질 함량을 $25\~50\%$로 실험한 결과, 단백질 함량 $40\%$에서 가장 높은 생존율과 빠른 성장을 보였고, 단백질 함량 25, 30, 35, 40, 45, $50\%$인 배합사료를 대하에 공급하였을때 생존율은 각각 74.0, 82.0, 91.0, 97.0, 93.0, $88.0\%$이었다. 최적의 사료내 단백질 함량은 $13\~84mg$인 대하 치하는 $40.4\%$, $0.9\~8.1g$ 인 대하는 $39.9\%$로 계산되었다. 사료중 단백질원을 어분 대신 대두백으로 대체할 때에는 대두박 함량을 $0.0\~76.0\%$로 실험한 결과, 대두백 함량이 많아질수록 생존율과 성장이 둔화되는 경향을 보였지만, 오징어유를 대두박 함량의 $2.5\%$ 첨가하였을때 생존율은 향상되었다.

  • PDF

비소세포폐암 환자에시 Ki-67 단백질 발현증가의 임상적 의의 (Clinical Significance of Increased Ki-67 Protein Expression in Non-small Cell Lung Cancers)

  • 이건;임창영;김광일;이헌재
    • Journal of Chest Surgery
    • /
    • 제39권5호
    • /
    • pp.376-381
    • /
    • 2006
  • 배경: Ki-67 단백질은 세포의 증식활성도를 나타내는 생물표식자로, 비소세포폐암 환자에서 Ki-67 단백질의 증가는 예후에 나쁜 영향을 미치는 것으로 알려져 있다. 이 연구는 비소세포폐암으로 폐절제술을 실시한 환자에서 Ki-67 단백질의 발현정도를 조사하여, 단백질의 발현증가가 환자의 임상적 병리적 양상과 술 후 재발과 생존기간에 미치는 영향을 알아보기 위해 시행되었다. 대상 및 방법: 근치적 폐절제술을 실시한 38명의 비소세포폐암 조직에서 단클론항체 Ki-67로 면역조직화학염색을 실시하여 Ki-67 Labeling Index (LI)를 구하였다. 환자를 Ki-67 증가군$(LI{\ge}20%)$과 Ki-67 비증가군(LI<20%)으로 분류하여, 두 군의 술 전 임상적 병리적 특성, 술 후 생존기간 및 무병생존기간을 비교하였다. 결과: Ki-67 LI는 불균질한 분포를 보였고 평균 LI는 $20.0{\pm}20.1%$였다. Ki-67 증가군과 비증가군 간에나이, 성별, 흡연, TNM 병기, 혈관침윤은 유의한 차이가 없었다. 그러나 증가군은 비증가군에 비해 편평상피암이 많고, 분화도가 나쁘며, 임파침윤이 많았다$(p{\le}0.05)$. 증가군은 중앙 생존기간(47.2 vs. 96.5개월)과 중앙 무병생존기간(18.2 vs. 72.3개월)이 비증가군보다 짧았으나 통계적 유의성은 없었다(각각 p=0.312, p=0.327). 결론: 이상의 연구를 통해 비소세로폐암 환자에서의 Ki-67 단백질 발현증가는 수술 후 환자의 예후에 나쁜 인자로 작용하여 생존기간과 무병생존기간이 짧아지는 경향을 보였으나 통계적 유의성이 부족하여 향후 지속적인 연구가 필요할 것이다.

Bacillus thuringiensis 유래 Vip3Aa 단백질 순수분리 및 꿀벌 (Apis mellifera)에 대한 위해성평가 (Purification and risk assessment of Bacillus thuringiensis Vip3Aa protein against Apis mellifera)

  • 정영준;유수향;이중로
    • 환경생물
    • /
    • 제37권4호
    • /
    • pp.585-591
    • /
    • 2019
  • 본 연구는 LMO 유전산물의 위해성평가를 위해 바실러스로부터 증폭된 Vip3Aa 유전자를 이용하여 대장균에서 단백질 순수분리 하였으며, MALDI-TOP 분석법을 통해 기존의 알려진 살충성 Vip3Aa 단백질과 동등한 단백질임을 증명하였다. 순수 분리한 Vip3Aa 단백질을 이용하여 꿀벌 과독성 급성섭식독성평가를 수행하였다. 그 결과 무처리군, Hepes buffer, Vip3Aa 단백질 처리군 모두 치사 및 일반 중독증상을 보이는 개체는 발견되지 않았다. 이 결과를 통해 Vip3Aa 단백질은 꿀벌에 위해성을 나타내지 않는다는 결론을 얻을 수 있었다. 본 연구 결과는 향후 국내 LMO 유전자 산물 위해성평가에 유용하게 활용될 것이라 사료된다.

Aberrant DNA Methylation and Epigenetic Inactivation of hMSH2 Decrease Overall Survival of Acute Lymphoblastic Leukemia Patients via Modulating Cell Cycle and Apoptosis

  • Wang, Cai-Xia;Wang, Xiang;Liu, Hai-Bai;Zhou, Zhi-Heng
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권1호
    • /
    • pp.355-362
    • /
    • 2014
  • Objective: Altered regulation of many transcription factors has been shown to play important roles in the development of leukemia. hMSH2 can modulate the activity of some important transcription factors and is known to be a regulator of hematopoietic differentiation. Herein, we investigated epigenetic regulation of hMSH2 and its influence on cell growth and overall survival of acute lymphoblastic leukemia (ALL) patients. Methods: hMSH2 promoter methylation status was assessed by COBRA and pyrosequencing in 60 ALL patients and 30 healthy volunteers. mRNA and protein expression levels of hMSH2, PCNA, CyclinD1, Bcl-2 and Bax were determined by real time PCR and Western blotting, respectively. The influence of hMSH2 on cell proliferation and survival was assessed in transient and stable expression systems. Results: mRNA and protein expression of hMSH2 and Bcl-2 was decreased, and that of PCNA, CyclinD1 and Bax was increased in ALL patients as compared to healthy volunteers (P<0.05). hMSH2 was inactivated in ALL patients through promoter hypermethylation. Furthermore, hMSH2 hypermethylation was found in relapsed ALL patients (85.7% of all cases). The median survival of patients with hMSH2 methylation was shorter than that of patients without hMSH2 methylation (log-rank test, P=0.0035). Over-expression of hMSH2 in cell lines resulted in a significant reduction in growth and induction of apoptosis. Conclusions: This study suggests that aberrant DNA methylation and epigenetic inactivation of hMSH2 play an important role in the development of ALL through altering cell growth and survival.